Press Releases

Press Releases

Teikoku Pharma USA (TPU) announced today that it has submitted a 505(b)(2) New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Docetaxel Injection Concentrate, Non-Alcohol Formula on February 26, 2015 and received an acknowledgment of the receipt from FDA. Docetaxel Injection Concentrate, Non-Alcohol Formula is for…

Press Releases

Not one, but two initiatives from Janssen Healthcare Innovation have beenseparately voted ‘Most Valuable’at the eyeforpharma Barcelona Awards. This is the first time a single company has won on multiple fronts at this ceremony. The eyeforpharma Barcelona Awards uniquelysupport pharmaceutical companies who prioritise value for patients and customers. The Orthopaedic…

Press Releases

Sanofi Pasteur’s global awareness programme for Dengue Fever, ‘Break Dengue’, was yesterday announced the winner of the ‘Most Impactful Emerging or Global Initiative’ category at the eyeforpharma Barcelona Awards, following a unanimous vote by the panel of international industry experts and patient advocates. The eyeforpharma Barcelona Awards uniquely support pharmaceutical…

Press Releases

Two of UCB’s biggest patient innovators were yesterday announced as winners at the eyeforpharma Barcelona Awards for their long-term commitment to improve patient experience. Both Christi Marsh, Director of North American Medical Information and Communications and the brains behind UCBCares, and departing CEO Roch Doliveux, were commended for their innovation…

Press Releases

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and difficult to manufacture proteins, announced today that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) in connection with the…

Press Releases

EUSA Pharma, a newly-established profitable specialty pharmaceutical business with global reach, today announced its official launch following the acquisition of five approved specialty hospital products, a multi-national commercial infrastructure and the EUSA Pharma brand name from Jazz Pharmaceuticals plc (Jazz).  The new company is led by Chief Executive Bryan Morton,…

Press Releases

Russian pharmaceutical market is developing rapidly, it takes 11th place in the rating of pharmaceutical markets' volume in the world and is predicted to go up to the 9th place by 2016. Along with growing potential, important changes in the industry take place due to governmental program “Pharma 2020”. With…

Press Releases

Anthera Pharmaceuticals, Inc. today announced it has received an award from Cystic Fibrosis Foundation Therapeutics Inc. of up to $3 million to support the manufacturing and clinical development of Anthera's novel pancreatic enzyme replacement therapy, Sollpura™ (liprotamase).   Cystic Fibrosis Foundation Therapeutics is a non-profit affiliate of the Cystic Fibrosis Foundation.…

Press Releases

Nektar Therapeutics reported that partner AstraZeneca today announced a co-commercialisation agreement with Daiichi Sankyo, Inc. for MOVANTIK™ (naloxegol) in the US, in line with the Company's strategy of delivering value through its own development and commercial capabilities as well as through external collaboration. MOVANTIK is a first-in-class once-daily oral peripherally-acting…

Press Releases

Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) for the treatment of pulmonary arterial…